GPBAR1 and Insulin resistance: From an inflammation regulation perspective, TGR5-mediated inhibition of the NF-kB signaling pathway can substantially decrease the expression levels of proinflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), thereby mitigating insulin resistance associated with chronic inflammation [66,115].